Implications of postvaccination hepatitis B surface antigenemia in the management of exposures to body fluids

Infection Control and Hospital Epidemiology

Volumn 25, Issue 7, 2004, Pages 611-613

  Martín Ancel, Ana ^a   Casas, María Luisa ^a   Bonet, Bartolomé ^a  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; RECOMBINANT HEPATITIS B VACCINE;

ANTIBODY TITER; ANTIGEN DETECTION; ARTICLE; CASE REPORT; CLINICAL FEATURE; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION PREVENTION; INFECTION RISK; NEEDLESTICK INJURY; NEWBORN; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; RISK FACTOR; VACCINATION;

ADULT; BODY FLUIDS; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; INFANT, NEWBORN; INFECTION CONTROL; NEEDLESTICK INJURIES; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; SEROLOGIC TESTS;

EID: 3242658384     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502449     Document Type: Article

References (11)

1. International Health Care Worker Safety Center, University of Virginia Health System. Annual Number of Occupational Percutaneous Injuries and Mucocutaneous Exposures to Blood or Potentially Infective Biological Substances. Charlottesville, VA: University of Virginia Health System; 1998. Available at www.healthsystem.virginia.edu/internet/epinet/ estimates.cfm. Accessed June 15, 2004.
2. Challapalli M, Slosar M, Vasa R, Cunningham DG. Brief surface anti-genemia in newborn infants vaccinated with hepatitis B vaccine. Pediatr Infect Dis J 1993;12:878-879.
3. Bernstein SR, Krieger P, Puppala BL, Costello M. Incidence and duration of hepatitis B surface antigenemia after neonatal hepatitis B immunization. J Pediatr 1994;125:621-622.
4. Weintraub Z, Khamaysi N, Elena H, Gershtein V, Orenstein L, Lahat N. Transient surface antigenemia in newborn infants vaccinated with Engerix B: occurrence and duration. Pediatr Infect Dis J 1994;13:931-933.
5. Köksal N, Altinkaya N, Perk Y. Transient hepatitis B surface antigenemia after neonatal hepatitis B immunization. Acta Paediatr 1996;85:1501-1502.
6. Katkov WN, Ault MJ, Dubin SB. Absence of hepatitis B surface antigenemia after vaccination. Arch Pathol Lab Med 1989;113:1290.
7. Kloster B, Kramer R, Eastlund T, Grossman B, Zarvan B. Hepatitis B surface antigenemia in blood donors following vaccination. Transfusion 1995;35:475-477.
8. Janzen L, Minuk GY, Fast M, Bernstein KN. Vaccine-induced hepatitis B surface antigen positivity in adult hemodialysis patients: incidental and surveillance data. J Am Soc Nephrol 1996;7:1228-1234.
9. Otag F, Mert A, Yilmaz G. Temporary deferral of blood donors after administration of hepatitis B vaccine. Transfusion 1997;37:880.
10. Santana Rodríguez OE, Morillas Jarillo C, Esparza Martín N, Toledo González A, Checa Andrés MD, Martín Sánchez AM. Transient blood surface antigens of hepatitis B in patients on hemodialysis. Rev Clin Esp 1999;199:198-201.
11. Ly D, Yee HF, Brezina M, Martin P, Gitnick G, Saab S. Hepatitis B surface antigenemia in chronic hemodialysis patients: effect of hepatitis B immunization. Am J Gastroenterol 2002;97:138-141.